SK

Sunil Kumar Khemani

Active Director Director DIN 07561798
DIN 07561798 First appointment Feb 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Sunil Kumar Khemani

Data last updated:

Sunil Kumar Khemani is a Director at Avizen Biopharma Private Limited (since 2017). The company operates in Pharma. Avizen Biopharma Private Limited reported revenue of ₹20.61 Cr (FY 2025).

DIN 07561798
Primary Designation Director
Industry Pharma
First Appointment 25 Feb 2017
Oldest Company Age 10 yrs
Largest company Avizen Biopharma Private Limited · ₹20.61 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avizen Biopharma Private Limited U24304AS2016PTC017532
Director25 Feb 20172016₹20.61 Cr (FY 2025)Active

Board colleagues of Sunil Kumar Khemani

Directorship timeline

Open interactive timeline →
Avizen Biopharma Private Limited
Premium access

Shareholding and investment profile for Sunil Kumar Khemani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Khemani

Sunil Kumar Khemani currently holds 1 directorship: Avizen Biopharma Private Limited (Director, since 25 Feb 2017, revenue ₹20.61 Cr (FY 2025)).

Sunil Kumar Khemani was first appointed on 25 Feb 2017 as Director at Avizen Biopharma Private Limited.

The current boards of Sunil Kumar Khemani's companies include Alka Verma (Avizen Biopharma Private Limited), Mahendra Kumar Verma (Avizen Biopharma Private Limited), Rajendra Kumar Verma (Avizen Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available